These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31282210)

  • 1. Pentraxin 3 as a marker of endothelial dysfunction in young women with polycystic ovary syndrome (PCOS).
    Wyskida K; Franik G; Pohl N; Markuszewski L; Owczarek A; Madej P; Chudek J; Olszanecka-Glinianowicz M
    Scand J Clin Lab Invest; 2019 Oct; 79(6):419-423. PubMed ID: 31282210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is pentraxin 3 a new cardiovascular risk marker in polycystic ovary syndrome?
    Sari U; Kaygusuz I; Kafali H
    Gynecol Obstet Invest; 2014; 78(3):173-8. PubMed ID: 25011417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome.
    Tosi F; Di Sarra D; Bonin C; Zambotti F; Dall'Alda M; Fiers T; Kaufman JM; Donati M; Franchi M; Zanolin ME; Bonora E; Moghetti P
    Eur J Endocrinol; 2014 Mar; 170(3):401-9. PubMed ID: 24347428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL; Brinkworth GD; Noakes M; Clifton PM; Norman RJ; Buckley JD
    Hum Reprod; 2012 Jul; 27(7):2169-76. PubMed ID: 22552687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study.
    Jin C; Zou K; Xu Y; Yang H; Pan J
    BMC Endocr Disord; 2021 Dec; 21(1):240. PubMed ID: 34856980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
    Usselman CW; Yarovinsky TO; Steele FE; Leone CA; Taylor HS; Bender JR; Stachenfeld NS
    J Physiol; 2019 Jun; 597(11):2853-2865. PubMed ID: 30847930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome.
    Koleva DI; Orbetzova MM; Nikolova JG; Tyutyundzhiev SB
    Arch Physiol Biochem; 2016 Oct; 122(4):223-227. PubMed ID: 27245110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation.
    Wyskida K; Franik G; Choręza P; Pohl N; Markuszewski L; Owczarek A; Madej P; Chudek J; Olszanecka-Glinianowicz M
    Int J Endocrinol; 2020; 2020():1380176. PubMed ID: 32934654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
    Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
    Rajendran S; Willoughby SR; Chan WP; Liberts EA; Heresztyn T; Saha M; Marber MS; Norman RJ; Horowitz JD
    Atherosclerosis; 2009 Jun; 204(2):509-14. PubMed ID: 19027116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentration of soluble intercellular adhesion molecule-1 in women with polycystic ovary syndrome.
    Nasiek M; Kos-Kudła B; Ostrowska Z; Marek B; Kajdaniuk D; Siemińska L; Foltyn W
    Gynecol Endocrinol; 2004 Oct; 19(4):208-15. PubMed ID: 15724804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma asymmetric dimethylarginine levels in children with beta-thalassemia major may be an early marker for endothelial dysfunction.
    Gursel O; Tapan S; Sertoglu E; Taşçılar E; Eker I; Ileri T; Uysal Z; Kurekci AE
    Hematology; 2018 Jun; 23(5):304-308. PubMed ID: 29086658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress on the role of pentraxin 3 in polycystic ovary syndrome].
    Wu W; Xu J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):637-643. PubMed ID: 33210493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?
    Sahin FK; Sahin SB; Balik G; Ural UM; Tekin YB; Cure MC; Senturk S; Yuce S; Cure E
    Int J Clin Exp Med; 2014; 7(10):3512-9. PubMed ID: 25419391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
    Bayram F; Kocer D; Ozsan M; Muhtaroglu S
    Gynecol Endocrinol; 2012 Jul; 28(7):497-501. PubMed ID: 22703625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed characterisation of circulatory nitric oxide and free radical indices--is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome?
    Willis GR; Udiawar M; Evans WD; Blundell HL; James PE; Rees DA
    BJOG; 2014 Dec; 121(13):1596-603. PubMed ID: 24816317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.